1. Home
  2. CTSO vs VNCE Comparison

CTSO vs VNCE Comparison

Compare CTSO & VNCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.69

Market Cap

45.9M

Sector

Health Care

ML Signal

HOLD

Logo Vince Holding Corp.

VNCE

Vince Holding Corp.

HOLD

Current Price

$4.33

Market Cap

53.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTSO
VNCE
Founded
1997
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
45.9M
53.8M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
CTSO
VNCE
Price
$0.69
$4.33
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$5.38
$4.88
AVG Volume (30 Days)
124.8K
250.3K
Earning Date
11-13-2025
02-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$36,979,520.00
$296,250,000.00
Revenue This Year
$7.26
$4.06
Revenue Next Year
$9.78
$3.91
P/E Ratio
N/A
N/A
Revenue Growth
23.89
2.58
52 Week Low
$0.60
$1.02
52 Week High
$1.61
$6.00

Technical Indicators

Market Signals
Indicator
CTSO
VNCE
Relative Strength Index (RSI) 47.73 73.77
Support Level $0.61 $3.30
Resistance Level $0.77 $4.65
Average True Range (ATR) 0.06 0.35
MACD 0.00 0.12
Stochastic Oscillator 53.86 77.86

Price Performance

Historical Comparison
CTSO
VNCE

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.

Share on Social Networks: